Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T J Powell

Showing results (31-40 of 38) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 38 results.
Vaccine|September 14, 2006
Vaccination with recombinant fusion proteins incorporating Toll-like receptor ligands induces rapid cellular and humoral immunityJames W Huleatt, Andrea R Jacobs, Jie Tang, et al.
Applied Occupational and Environmental Hygiene|October 8, 1999
Recommended default methodology for analysis of airborne exposures to mixtures of chemicals in emergenciesD K Craig, R L Baskett, J S Davis, et al.
Vaccine|December 8, 2007
Potent immunogenicity and efficacy of a universal influenza vaccine candidate comprising a recombinant fusion protein linking influenza M2e to the TLR5 ligand flagellinJames W Huleatt, Valerian Nakaar, Priyanka Desai, et al.
Cancer Research|January 19, 1999
SU5416 is a potent and selective inhibitor of the vascular endothelial growth factor receptor (Flk-1/KDR) that inhibits tyrosine kinase catalysis, tumor vascularization, and growth of multiple tumor typesT A Fong, L K Shawver, L Sun, et al.
The British Journal of Dermatology|December 3, 1999
Growth inhibition of psoriatic keratinocytes by quinazoline tyrosine kinase inhibitorsT J Powell, H Ben-Bassat, B Y Klein, et al.
The Journal of Infectious Diseases|May 2, 2007
A West Nile virus recombinant protein vaccine that coactivates innate and adaptive immunityWilliam F McDonald, James W Huleatt, Harald G Foellmer, et al.
Plos One|May 22, 2008
Efficacious recombinant influenza vaccines produced by high yield bacterial expression: a solution to global pandemic and seasonal needsLangzhou Song, Valerian Nakaar, Uma Kavita, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 1, 1997
Inhibition of platelet-derived growth factor-mediated signal transduction and tumor growth by N-[4-(trifluoromethyl)-phenyl]5-methylisoxazole-4-carboxamideL K Shawver, D P Schwartz, E Mann, et al.
Pageof 4

Showing results (31-40 of 38) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 38 results.
Vaccine|September 14, 2006
Vaccination with recombinant fusion proteins incorporating Toll-like receptor ligands induces rapid cellular and humoral immunityJames W Huleatt, Andrea R Jacobs, Jie Tang, et al.
Applied Occupational and Environmental Hygiene|October 8, 1999
Recommended default methodology for analysis of airborne exposures to mixtures of chemicals in emergenciesD K Craig, R L Baskett, J S Davis, et al.
Vaccine|December 8, 2007
Potent immunogenicity and efficacy of a universal influenza vaccine candidate comprising a recombinant fusion protein linking influenza M2e to the TLR5 ligand flagellinJames W Huleatt, Valerian Nakaar, Priyanka Desai, et al.
Cancer Research|January 19, 1999
SU5416 is a potent and selective inhibitor of the vascular endothelial growth factor receptor (Flk-1/KDR) that inhibits tyrosine kinase catalysis, tumor vascularization, and growth of multiple tumor typesT A Fong, L K Shawver, L Sun, et al.
The British Journal of Dermatology|December 3, 1999
Growth inhibition of psoriatic keratinocytes by quinazoline tyrosine kinase inhibitorsT J Powell, H Ben-Bassat, B Y Klein, et al.
The Journal of Infectious Diseases|May 2, 2007
A West Nile virus recombinant protein vaccine that coactivates innate and adaptive immunityWilliam F McDonald, James W Huleatt, Harald G Foellmer, et al.
Plos One|May 22, 2008
Efficacious recombinant influenza vaccines produced by high yield bacterial expression: a solution to global pandemic and seasonal needsLangzhou Song, Valerian Nakaar, Uma Kavita, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 1, 1997
Inhibition of platelet-derived growth factor-mediated signal transduction and tumor growth by N-[4-(trifluoromethyl)-phenyl]5-methylisoxazole-4-carboxamideL K Shawver, D P Schwartz, E Mann, et al.
Pageof 4